The company is a limited company approved by the Henan Economic System Reform Commission (1998) No. 38, with Zhengzhou Zhongsheng Industrial Group Co., Ltd. as the main sponsor, and co-sponsored by five companies including Henan Zhiyi Investment and Development Co., Ltd., Zhengzhou Zhulin Xianzhu Washing Products Co., Ltd., Zhengzhou Zhulin Refractory Materials Company, and Gongyi Zhulin Xinhua Packaging Materials Factory. Approved by the China Securities Regulatory Commission Securities Regulatory Commission, issue letter No. 98 [1999]. On August 13, 1999, the Japanese company issued 35 million public shares. The total share capital after issuance was 13,6145.24 million yuan. The company's main business is pharmaceutical manufacturing and drug research and development services, which specifically include the four segments of pharmaceutical preparation, traditional Chinese medicine tablets, drug research and development services, and pharmaceutical material distribution. The company's pharmaceutical business is mainly based on oral formulations of traditional Chinese medicines. The treatment areas cover respiratory, cardiovascular, digestive, neurological and gynecological diseases. The main products include Shuanghuanglian Oral Liquid series, Shuangjin conjugate, salvia oral liquid, pediatric fever and cough relief liquid, pediatric compound chicken chewable tablets, shavelin tablets, etc. Among them, Shuanghuanglian Oral Liquid (concentrated type), Shuanghuanglian Oral Liquid (children's type), Shuangjin Combinant, and Pediatric Compound Chicken Chewables are exclusive products of the company. Corporate honors: The Pharmaceutical Chamber of Commerce of the All-China Federation of Industry and Commerce awarded the company the honor of “anti-epidemic, charity and love”, high-tech enterprises in Henan Province, “National High-tech Industrialization Demonstration Project”, “Excellent Enterprise in Zhengzhou”, etc.